
The FDA grants accelerated approval to neladalkib for pretreated ALK-positive lung cancer, showing how next-gen kinase inhibitors tackle drug resistance
CPI, a CDMO specializing in Wurster fluid bed coating, has designed and optimized their equipment to create quality coated products.






